Ovid Therapeutics Inc.
RECOMBINANT ADENO-ASSOCIATED VECTORS
Last updated:
Abstract:
Adeno-associated virus (AAV) vectors and uses thereof are provided. More specifically, AAV vectors are provided that show specific tropism for certain target tissue, such as central nervous system (CNS) and adipose tissue, and which may be used to transduce cells for introduction of genes of interest into the target tissues. Pharmaceutical compositions are also provided that include AAV vectors and a pharmaceutically acceptable excipient, diluent or carrier.
Status:
Application
Type:
Utility
Filling date:
12 Aug 2021
Issue date:
2 Dec 2021